HERBERT J. CONRAD - 13 Jan 2021 Form 4 Insider Report for Matinas BioPharma Holdings, Inc. (MTNB)

Role: Director
Signature: /s/_ Keith A. Kucinski, attorney-in fact for Herbert J. Conrad
Issuer symbol: MTNB
Transactions as of: 13 Jan 2021
Net transactions value: $0
Form type: 4
Filing time: 24 May 2021, 17:30:18 UTC
Next filing: 21 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership
transaction	MTNB	Common Stock, par value $0.0001 per share	Gift	$0	-50,000	-9.2%	$0.000000	494,622	13 Jan 2021	Direct
transaction	MTNB	Common Stock, par value $0.0001 per share	Gift	$0	+50,000	+40%	$0.000000	175,000	13 Jan 2021	By Herbert J. Conrad Trust u/a/d 3/4/2005, Herbert J Conrad, Susan Wachtel, Nancy Fallick, Trustees
transaction	MTNB	Common Stock, par value $0.0001 per share	Gift	$0	-1,145,905	-100%	$0.000000^*	0	20 May 2021	By Herbert Conrad 2019 Grantor Retained Annuity Trust (GRAT)
transaction	MTNB	Common Stock, par value $0.0001 per share	Gift	$0	+1,145,905	+655%	$0.000000	1,320,905	20 May 2021	By Herbert J. Conrad Trust u/a/d 3/4/2005, Herbert J Conrad, Susan Wachtel, Nancy Fallick, Trustees
holding	MTNB	Common Stock, par value $0.0001 per share						2,639,039	13 Jan 2021	By Herbert Conrad 2020 Grantor Retained Annuity Trust (GRAT)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MTNB	Series B Convertible Preferred Stock	Gift	$100,000	-100	-100%	$1000.00^*	0	13 Jan 2021	Common Stock	200,000	$0.5000	Direct	F1
transaction	MTNB	Series B Convertible Preferred Stock	Gift	$100,000	+100		$1000.00^*	100	13 Jan 2021	Common Stock	200,000	$0.5000	By Herbert J. Conrad Trust u/a/d 3/4/2005, Herbert J Conrad, Susan Wachtel, Nancy Fallick, Trustees	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date.

Content

Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date.